Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis
- 22 October 2009
- journal article
- Published by SAGE Publications in Lupus
- Vol. 18 (14) , 1329-1330
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity?Lupus, 2009
- Proinflammatory cytokines (TNF-α and IL-6) in Egyptian patients with SLE: Its correlation with disease activityCytokine, 2006
- In Vivo Modulation of Soluble “Antagonistic” IL-6 Receptor Synthesis and Release in ESRDJournal of the American Society of Nephrology, 2005
- The Classification of Glomerulonephritis in Systemic Lupus Erythematosus RevisitedJournal of the American Society of Nephrology, 2004
- Reduced in vitro Production of Interferon-Gamma, Interleukin-4 and Interleukin-12 and Increased Production of Interleukin-6, Interleukin-10 and Tumour Necrosis Factor-Alpha in Systemic Lupus Erythematosus. Weak Correlations of Cytokine Production with Disease ActivityAutoimmunity, 1999
- In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activityLupus, 1996
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982